<![CDATA[Prostate Cancer Update]]>7e7c50d4-9239-5ced-a4d6-584dad67e6b1Tue, 31 Mar 2026 13:00:05 +0000Captivate.fmDr. Neil Lovehttps://artwork.captivate.fm/97635d70-f91b-4542-ac9e-4ad77eab0c7d/HDx77o9GuXjm3JsutW_azrxg.pngProstate Cancer UpdateDr. Neil LoveDr. Neil LoveFeaturing one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.https://www.researchtopractice.com/browse-tumor-types/prostate-cancerfalseepisodichttps://feeds.captivate.fm/prostate-oncology/nopodcastAKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers SymposiumAKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers SymposiumProf Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT inhibition in prostate cancer.

CME information and select publications here.

]]>Prof Karim Fizazi from the Centre Oscar Lambret in Lille, France, Dr Daniel George from the Duke Cancer Institute in Durham, North Carolina, and moderator Dr Elisabeth I Heath from Mayo Clinic in Rochester, Minnesota, discuss the future role of AKT inhibition in prostate cancer.

CME information and select publications here.

]]>39050ab0-fae4-407a-b2a1-d0a6dbfe1752Tue, 31 Mar 2026 09:00:00 -040001:29:22falsefull24363624Metastatic Bladder Cancer — Rapid Case Review Issue 3Metastatic Bladder Cancer — Rapid Case Review Issue 3Dr Matthew Milowsky from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, comments on real patient cases of metastatic urothelial bladder cancer presented by Dr Jacqueline T Brown from the Emory University School of Medicine in Atlanta, Georgia and Dr Nazli Dizman from The University of Texas MD Anderson Cancer Center in Houston.

CME information and select publications here.

]]>Dr Matthew Milowsky from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, comments on real patient cases of metastatic urothelial bladder cancer presented by Dr Jacqueline T Brown from the Emory University School of Medicine in Atlanta, Georgia and Dr Nazli Dizman from The University of Texas MD Anderson Cancer Center in Houston.

CME information and select publications here.

]]>e498e372-8e48-4f78-bf6e-2462e9d28eaaFri, 27 Mar 2026 11:00:00 -040032:43falsefull24353524Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers SymposiumNon-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers SymposiumDr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Dr Shilpa Gupta from Cleveland Clinic’s Taussig Cancer Institute in Ohio, Prof Andrea Necchi from IRCCS San Raffaele Hospital in Milan, Italy, and moderator Dr Terence Friedlander from the University of California, San Francisco discuss recent data surrounding the management of non-muscle-invasive and muscle-invasive bladder cancer, alongside their perspectives on clinical application and disease management.

CME information and select publications here.

]]>Dr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Dr Shilpa Gupta from Cleveland Clinic’s Taussig Cancer Institute in Ohio, Prof Andrea Necchi from IRCCS San Raffaele Hospital in Milan, Italy, and moderator Dr Terence Friedlander from the University of California, San Francisco discuss recent data surrounding the management of non-muscle-invasive and muscle-invasive bladder cancer, alongside their perspectives on clinical application and disease management.

CME information and select publications here.

]]>6e818e3b-dd71-4b66-bd82-39bb06072725Wed, 25 Mar 2026 14:30:00 -040001:58:06falsefull24343424Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 ReviewUrothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 ReviewDr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.

CME information and select publications here.

]]>Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.

CME information and select publications here.

]]>42363c5c-a41d-4929-b334-2085b5886ea1Mon, 23 Feb 2026 14:30:00 -040023:29falsefull24333324Metastatic Bladder Cancer — Rapid Case Review Issue 2Metastatic Bladder Cancer — Rapid Case Review Issue 2Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, present real patient cases on metastatic bladder cancer, with additional commentary from Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York.

CME information and select publications here.

]]>Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, present real patient cases on metastatic bladder cancer, with additional commentary from Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York.

CME information and select publications here.

]]>12a73860-879a-44ec-9106-09b1c5ccc0efTue, 17 Feb 2026 14:30:00 -040029:11falsefull24323224Prostate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 ReviewProstate Cancer — Microlearning Activity 2 with Dr Rana R McKay: ESMO Congress 2025 ReviewDr McKay discusses the selection of and efficacy data with androgen pathway-targeting agents for patients with prostate cancer and reviews recently presented clinical findings from the ESMO Congress 2025.

CME information and select publications here.

]]>Dr McKay discusses the selection of and efficacy data with androgen pathway-targeting agents for patients with prostate cancer and reviews recently presented clinical findings from the ESMO Congress 2025.

CME information and select publications here.

]]>a27d6bf1-155f-42fd-b6c0-d028e886a2d2Tue, 10 Feb 2026 16:00:00 -040018:06falsefull24313124Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 ReviewUrothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 ReviewDr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.

CME information and select publications here.

]]>Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress.

CME information and select publications here.

]]>50861479-ac95-4180-85dc-df028f3ae179Wed, 04 Feb 2026 16:00:00 -040031:09falsefull24303024Prostate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 ReviewProstate Cancer — Microlearning Activity 1 with Dr Rana R McKay: ESMO Congress 2025 ReviewDr Rana R McKay discusses the selection and sequencing of therapy for patients with prostate cancer in a review of recently presented clinical findings from ESMO Congress 2025.

CME information and select publications here.

]]>Dr Rana R McKay discusses the selection and sequencing of therapy for patients with prostate cancer in a review of recently presented clinical findings from ESMO Congress 2025.

CME information and select publications here.

]]>dad9e622-e508-463e-b1e5-ef198a2466d3Thu, 29 Jan 2026 15:30:00 -040018:08falsefull24292924Metastatic Bladder Cancer — Rapid Case Review Issue 1Metastatic Bladder Cancer — Rapid Case Review Issue 1Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, present real patient cases on metastatic bladder cancer, with additional commentary from Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York.

CME information and select publications here.

]]>Dr Catherine Fahey from the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Fern Anari from the Fox Chase Cancer Center in Philadelphia, Pennsylvania, present real patient cases on metastatic bladder cancer, with additional commentary from Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York.

CME information and select publications here.

]]>bc640d3f-5eaa-4fbb-9406-d38c4148465cFri, 23 Jan 2026 12:49:00 -040027:27falsefull24282824Urothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual MeetingUrothelial Bladder Cancer and Prostate Cancer — Highlights from the 2025 ESMO Annual MeetingDr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center and Dr Rana R McKay from the UC San Diego Moores Cancer Center summarize the treatment landscape for prostate and urothelial bladder cancer and discuss the implications of clinical findings recently presented at the ESMO Congress 2025.

CME information and select publications here.

]]>Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center and Dr Rana R McKay from the UC San Diego Moores Cancer Center summarize the treatment landscape for prostate and urothelial bladder cancer and discuss the implications of clinical findings recently presented at the ESMO Congress 2025.

CME information and select publications here.

]]>b3a95dbe-30c1-446d-ba53-2089f26beb90Fri, 19 Dec 2025 14:30:00 -040001:01:32falsefull24272724Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research InstituteProstate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research InstituteDr Emmanuel S Antonarakis and Dr Matthew R Smith share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. 

CME information and select publications here.

]]>Dr Emmanuel S Antonarakis and Dr Matthew R Smith share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. 

CME information and select publications here.

]]>ef6dcc63-eb29-4dd5-87b3-22760df30069Tue, 11 Nov 2025 14:30:00 -040054:28falsefull24262624Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future ManagementExtrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future ManagementDr Jonathan Strosberg from Moffitt Cancer Center in Tampa, Florida, discusses recent updates on available and novel treatment strategies for extrapulmonary neuroendocrine carcinoma. 

CME information and select publications here.

]]>Dr Jonathan Strosberg from Moffitt Cancer Center in Tampa, Florida, discusses recent updates on available and novel treatment strategies for extrapulmonary neuroendocrine carcinoma. 

CME information and select publications here.

]]>23f51ebf-cb25-4e2e-9979-150e98838de9Mon, 22 Sep 2025 14:30:00 -040044:34falsefull24252524Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient CareOncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient CareMs Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer. 

NCPD information and select publications here.

]]>Ms Kathleen D Burns from City of Hope Comprehensive Cancer Center in Duarte, California, discusses nursing considerations in the care of patients with prostate cancer. 

NCPD information and select publications here.

]]>7cbc6587-0430-467c-af54-5e06495d24cfThu, 31 Jul 2025 13:00:00 -040044:11falsefull24242424Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual MeetingRenal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual MeetingProf Laurence Albiges and Dr Tian Zhang summarize major findings presented at the 2025 ASCO Annual Meeting and review relevant ongoing clinical trials for patients with renal cell carcinoma. 

CME information and select publications here.

]]>Prof Laurence Albiges and Dr Tian Zhang summarize major findings presented at the 2025 ASCO Annual Meeting and review relevant ongoing clinical trials for patients with renal cell carcinoma. 

CME information and select publications here.

]]>da3ee467-e1fc-4d2f-a296-cd0bfb8abdbaThu, 24 Jul 2025 14:00:00 -040058:54falsefull24232324For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS CongressFor Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS CongressDr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>Dr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events. 

NCPD information and select publications here.

]]>0b9437a2-e7d4-4488-8d44-72bd7a5b04f1Tue, 15 Jul 2025 14:00:00 -040001:27:51falsefull24222224Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual MeetingUrothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual MeetingDr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Prof Andrea Necchi from the IRCCS San Raffaele Hospital in Milan, Italy, and Prof Thomas Powles from the Barts Cancer Institute in London provide their perspectives on clinical scenarios and datasets informing the care of patients with urothelial bladder cancer. 

CME information and select publications here.

]]>Dr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Prof Andrea Necchi from the IRCCS San Raffaele Hospital in Milan, Italy, and Prof Thomas Powles from the Barts Cancer Institute in London provide their perspectives on clinical scenarios and datasets informing the care of patients with urothelial bladder cancer. 

CME information and select publications here.

]]>8bf15305-63ce-4373-8226-fa1dae20f06aFri, 11 Jul 2025 08:00:00 -040001:00:11falsefull24212124Prostate Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual MeetingProstate Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual MeetingDr Neeraj Agarwal from the University of Utah Huntsman Cancer Institute in Salt Lake City, Dr Andrew J Armstrong from Duke Cancer Institute in Durham, North Carolina, Dr Himisha Beltran from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Fred Saad from the University of Montreal Hospital Center in Québec, Canada, and Dr Rana R McKay from the UC San Diego Moores Cancer Center discuss recent updates on available and novel treatment strategies for prostate cancer. 

CME information and select publications here.

]]>Dr Neeraj Agarwal from the University of Utah Huntsman Cancer Institute in Salt Lake City, Dr Andrew J Armstrong from Duke Cancer Institute in Durham, North Carolina, Dr Himisha Beltran from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Fred Saad from the University of Montreal Hospital Center in Québec, Canada, and Dr Rana R McKay from the UC San Diego Moores Cancer Center discuss recent updates on available and novel treatment strategies for prostate cancer. 

CME information and select publications here.

]]>a41cc3d3-44a3-411a-ad84-56908f8726b2Thu, 26 Jun 2025 14:30:00 -040001:56:26falsefull24202024Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual MeetingProstate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual MeetingDr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer. 

CME information and select publications here.

]]>Dr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer. 

CME information and select publications here.

]]>a03cb3aa-9401-4c1f-b672-a1bdad561168Tue, 03 Jun 2025 15:00:00 -040001:22:55falsefull24191924Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology SummitUrothelial Bladder Cancer — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of urothelial bladder cancer.  

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of urothelial bladder cancer.  

CME information and select publications here.

]]>d9b7afcd-cf5a-4b92-9076-efab7e5e04bfThu, 22 May 2025 14:00:00 -040049:01falsefull24181824Prostate Cancer — Year in Review Series on Relevant New Datasets and AdvancesProstate Cancer — Year in Review Series on Relevant New Datasets and AdvancesDr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients. 

CME information and select publications here.

]]>Dr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients. 

CME information and select publications here.

]]>46980154-6115-46c3-8cbd-cfa47e24d400Thu, 15 May 2025 15:00:00 -040001:00:00falsefull24171724Prostate Cancer — Fourth Annual National General Medical Oncology SummitProstate Cancer — Fourth Annual National General Medical Oncology SummitClinical investigators discuss available data guiding the management of prostate cancers. 

CME information and select publications here.

]]>Clinical investigators discuss available data guiding the management of prostate cancers. 

CME information and select publications here.

]]>a89d5e4a-a374-43b4-9bb0-794d9a4fc3a8Tue, 29 Apr 2025 10:00:00 -040047:33falsefull24161624Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial UpdatesGenitourinary Cancers — An Interview with Dr William K Oh on Recent Trial UpdatesDr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers. 

CME information and select publications here.

]]>Dr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers. 

CME information and select publications here.

]]>232c6ffa-2265-435c-bf5c-c39146795cdcWed, 23 Apr 2025 08:01:00 -040044:21falsefull24151524Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)Dr Thomas Hutson from UMC Cancer Center in Lubbock, Texas, Dr Rana McKay from UC San Diego Moores Cancer Center in California, Dr Tian Zhang from UT Southwestern Medical Center in Dallas, and moderator Dr Sumanta Kumar Pal from City of Hope Comprehensive Cancer Center in Duarte, California, discuss published data and updates from the 2025 ASCO Genitourinary Cancers Symposium meeting on management strategies for clear cell and non-clear cell renal cell carcinoma.  

CME information and select publications here.

]]>Dr Thomas Hutson from UMC Cancer Center in Lubbock, Texas, Dr Rana McKay from UC San Diego Moores Cancer Center in California, Dr Tian Zhang from UT Southwestern Medical Center in Dallas, and moderator Dr Sumanta Kumar Pal from City of Hope Comprehensive Cancer Center in Duarte, California, discuss published data and updates from the 2025 ASCO Genitourinary Cancers Symposium meeting on management strategies for clear cell and non-clear cell renal cell carcinoma.  

CME information and select publications here.

]]>daf33701-fd38-481e-8a73-b94f4ee3b074Sun, 16 Mar 2025 06:00:00 -040001:58:34falsefull24141424Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)Drs Terence Friedlander, Matthew D Galsky, Neeraj Agarwal, Andrew J Armstrong and Elisabeth I Heath discuss recent updates on available and novel treatment strategies for bladder cancer and prostate cancer. 

CME information and select publications here.

]]>Drs Terence Friedlander, Matthew D Galsky, Neeraj Agarwal, Andrew J Armstrong and Elisabeth I Heath discuss recent updates on available and novel treatment strategies for bladder cancer and prostate cancer. 

CME information and select publications here.

]]>183398c8-9f35-4a4f-a7b9-7c64388fd084Sat, 08 Mar 2025 09:00:00 -040001:57:43falsefull24131324Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate CancerData + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate CancerSpecialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer.

]]>Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer.

]]>FF311A7B-0F85-4B04-92FB-9D1B9A797F9DWed, 20 Nov 2024 12:33:00 -040057:10falsefull24121224Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer.Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder CancerOncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder CancerDr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer.

]]>Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer.

]]>F2824FE1-6BBC-4189-B1DB-B72A3C0DBDB3Fri, 30 Aug 2024 10:01:00 -040030:46falsefull24111124Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer.Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate CancerOncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate CancerDr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer.

]]>Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer.

]]>C49C6E60-3952-49E4-8D70-358B55A37562Fri, 02 Aug 2024 13:14:00 -040053:35falsefull24101024Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer.Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual ReviewInvestigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual ReviewDr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma.

]]>Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma.

]]>499BFAB1-7762-4619-B39D-0BFD96ADF892Thu, 18 Jul 2024 10:14:00 -040001:02:25falsefull249924Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma.Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder CancerOncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder CancerDr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer.

]]>Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer.

]]>FDB0A620-F2EB-4FAB-8443-A1EF685A1A59Tue, 18 Jun 2024 11:12:00 -040001:23:42falsefull248824Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer.Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder CancerSecond Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder CancerDr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting.

]]>Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting.

]]>7AF1A02A-A314-41D6-A600-F67C96362936Fri, 07 Jun 2024 17:21:00 -040001:02:32falsefull247724Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting.Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part EditionOncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part EditionDr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.

]]>Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.

]]>D68DC33D-1753-4CD6-A320-DA621FECEA3FTue, 07 May 2024 10:49:00 -040001:07:29falsefull246624Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field.Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers SymposiumOncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers SymposiumDr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer.

]]>Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer.

]]>D87EF6FB-5A59-440A-8BFC-F4E29D89F89DThu, 25 Apr 2024 10:27:00 -040059:59falsefull245524Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder CancerYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder CancerDr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.

]]>Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.

]]>32795082-5E7C-466A-86ED-552C69D355ACFri, 05 Apr 2024 09:52:00 -040001:00:56falsefull244424Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer.Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug ConjugatesOncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug ConjugatesDr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.

]]>Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.

]]>8898EC41-26EC-45FD-9E50-64B87AB644CCThu, 04 Apr 2024 09:42:00 -040001:14:03falsefull243324Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate CancerYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate CancerDr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer.

]]>Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer.

]]>AAF00088-DF08-4006-B604-6871C03280B4Thu, 28 Mar 2024 08:34:00 -040001:01:37falsefull242224Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer.Virtual Case Library: Metastatic Urothelial Bladder CancerVirtual Case Library: Metastatic Urothelial Bladder CancerDrs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer.

]]>Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer.

]]>323D3BA4-5632-4271-A2FA-02C405EEC8F0Wed, 13 Mar 2024 06:27:00 -040002:08:14falsefull241124Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer.Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate CancerInside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate CancerDr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.

]]>Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.

]]>68740D8D-E87F-40AF-AFA9-184B0CC8B7C2Fri, 01 Sep 2023 16:07:00 -040001:01:01falsefull23111123Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingOncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingDr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting.

]]>Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting.

]]>C189F608-DA34-4A79-9826-52668C8E1D98Fri, 25 Aug 2023 11:07:00 -040001:20:38falsefull23101023Dr Rana McKay from UC San Diego Moores Cancer Center in La Jolla, California discusses key presentations on genitourinary cancers from the 2023 ASCO Annual Meeting.Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate CancerReady for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate CancerFeaturing a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love.

]]>Featuring a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love.

]]>0CF2C31F-71F9-4971-B495-6FA140DEA3DCMon, 14 Aug 2023 11:40:00 -040002:48:58falsefull239923Featuring a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love.Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder CancerInside the Issue: Optimizing the Management of Metastatic Urothelial Bladder CancerDr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Professor Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discuss available and novel treatment strategies for metastatic urothelial bladder cancer, moderated by Dr Neil Love.

]]>Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Professor Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discuss available and novel treatment strategies for metastatic urothelial bladder cancer, moderated by Dr Neil Love.

]]>FC5B674B-F7C0-4D0A-A5DF-FE06B075F8CAThu, 10 Aug 2023 09:58:00 -040001:02:12falsefull238823Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Professor Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discuss available and novel treatment strategies for metastatic urothelial bladder cancer, moderated by Dr Neil Love.Management of Urothelial Bladder Cancer with Dr Matthew GalskyManagement of Urothelial Bladder Cancer with Dr Matthew GalskyDr Matthew Galsky from The Tisch Cancer Institute in New York, New York, discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer, moderated by Dr Neil Love.

]]>Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York, discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer, moderated by Dr Neil Love.

]]>7FB8389B-4037-4F96-B2C9-08BE6CF39A80Mon, 24 Jul 2023 10:20:00 -040056:37falsefull237723Dr Matthew Galsky from The Tisch Cancer Institute in New York, New York, discusses recent updates from ASCO 2023 on the management of urothelial bladder cancer, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder CancerOncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Urothelial Bladder CancerFeaturing a discussion on the presentation and management of urothelial bladder cancer with Dr Elizabeth Plimack, moderated by Dr Neil Love.

]]>Featuring a discussion on the presentation and management of urothelial bladder cancer with Dr Elizabeth Plimack, moderated by Dr Neil Love.

]]>7AECA5FD-8CAD-4862-8B50-245E21220F2AThu, 20 Jul 2023 12:53:00 -040052:15falsefull236623Featuring a discussion on the presentation and management of urothelial bladder cancer with Dr Elizabeth Plimack, moderated by Dr Neil Love.Investigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell CarcinomaInvestigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell CarcinomaFeaturing perspectives from Dr David F McDermott and Dr Sumanta Kumar Pal, moderated by Dr Neil Love.

]]>Featuring perspectives from Dr David F McDermott and Dr Sumanta Kumar Pal, moderated by Dr Neil Love.

]]>F2E668A0-6F98-4A6E-81A1-380FA7457793Mon, 17 Jul 2023 11:44:00 -040001:00:22falsefull235523Featuring perspectives from Dr David F McDermott and Dr Sumanta Kumar Pal, moderated by Dr Neil Love.What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder CancerWhat I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder CancerProceedings from a webinar held in partnership with the 2023 ONS Congress. Featuring a discussion on the management of urothelial bladder cancer with Ms Brenda Martone and Dr Jonathan E Rosenberg, moderated by Dr Neil Love.

]]>Proceedings from a webinar held in partnership with the 2023 ONS Congress. Featuring a discussion on the management of urothelial bladder cancer with Ms Brenda Martone and Dr Jonathan E Rosenberg, moderated by Dr Neil Love.

]]>944A7994-BEA4-4846-A3B9-808D26C98653Fri, 23 Jun 2023 10:41:00 -040001:04:07falsefull234423Proceedings from a webinar held in partnership with the 2023 ONS Congress. Featuring a discussion on the management of urothelial bladder cancer with Ms Brenda Martone and Dr Jonathan E Rosenberg, moderated by Dr Neil Love.Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU ActivityOncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU ActivityD28CDADE-F60E-4D09-B6D1-102B602870B3Fri, 05 May 2023 12:33:45 -040001:02:15falsefullFeaturing perspectives from Drs Andrew J Armstrong and Rana R McKay, moderated by Dr Neil Love. Oncology Today with Dr Neil Love: Special Edition — Recent Research Advances in Prostate Cancer and the Clinical Implications (Faculty Interview)Oncology Today with Dr Neil Love: Special Edition — Recent Research Advances in Prostate Cancer and the Clinical Implications (Faculty Interview)3650714C-F1B6-4612-9A7F-E7F52FE42C2FFri, 05 May 2023 12:33:20 -040052:58falsefullFeaturing perspectives from Dr Daniel Petrylak, moderated by Dr Neil Love. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder CancerYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer745AAAAE-2BD3-4A25-A526-0309C4B9AADDTue, 18 Apr 2023 15:42:31 -040001:03:09falsefullProceedings from our Year in Review webinar on the management of renal cell carcinoma and bladder cancer. Featuring perspectives from Dr Matthew Milowsky and Prof Thomas Powles, moderated by Dr Neil Love. Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate CancerYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate CancerProceedings from our Year in Review webinar on the management of prostate cancer. Featuring perspectives from Drs Tanya Dorff and A Oliver Sartor, moderated by Dr Neil Love.

]]>Proceedings from our Year in Review webinar on the management of prostate cancer. Featuring perspectives from Drs Tanya Dorff and A Oliver Sartor, moderated by Dr Neil Love.

]]>EB10E391-CCCC-483B-9D5D-FF9667A8866BThu, 06 Apr 2023 10:59:00 -040001:01:42falsefull233323Proceedings from our Year in Review webinar on the management of prostate cancer. Featuring perspectives from Drs Tanya Dorff and A Oliver Sartor, moderated by Dr Neil Love.Recent Advances and Future Directions in Genitourinary Cancers — With Dr Daniel Petrylak and Dr Sandy Srinivas (Proceedings from a Symposium in Partnership with NCOA and SCOS)Recent Advances and Future Directions in Genitourinary Cancers — With Dr Daniel Petrylak and Dr Sandy Srinivas (Proceedings from a Symposium in Partnership with NCOA and SCOS)Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

]]>Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

]]>A9D942C3-11FF-4C9D-BD90-534D0B4392D7Fri, 17 Mar 2023 12:31:00 -040059:28falsefull232223Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder CancerOncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder CancerFeaturing a discussion on current treatments for metastatic urothelial bladder cancer with Dr Scott Tagawa, moderated by Dr Neil Love.

]]>Featuring a discussion on current treatments for metastatic urothelial bladder cancer with Dr Scott Tagawa, moderated by Dr Neil Love.

]]>3EF1B9E0-5001-4B02-867F-6EA21AB81965Thu, 05 Jan 2023 10:37:00 -040056:08falsefull231123Featuring a discussion on current treatments for metastatic urothelial bladder cancer with Dr Scott Tagawa, moderated by Dr Neil Love.Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2 of a 2-Part SeriesMeet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2 of a 2-Part SeriesFeaturing a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.

]]>Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.

]]>360CEDD3-6EAE-45AF-9437-1025ED239A3BWed, 07 Dec 2022 11:51:00 -040001:01:48falsefull226622Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Prof Karim Fizazi and Prof Stéphane Oudard, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Management of Renal Cell CarcinomaOncology Today with Dr Neil Love: Management of Renal Cell CarcinomaFeaturing a discussion on recent advances in the treatment of renal cell carcinoma with Dr Toni Choueiri, moderated by Dr Neil Love.

]]>Featuring a discussion on recent advances in the treatment of renal cell carcinoma with Dr Toni Choueiri, moderated by Dr Neil Love.

]]>8C192663-520B-40EC-904A-7B94AE83669FTue, 29 Nov 2022 09:22:00 -040040:33falsefull225522Featuring a discussion on recent advances in the treatment of renal cell carcinoma with Dr Toni Choueiri, moderated by Dr Neil Love.The Clinical Implications of Key Recent Data Sets in Prostate and Bladder Cancers — With Drs Alicia Morgans and Evan Yu (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)The Clinical Implications of Key Recent Data Sets in Prostate and Bladder Cancers — With Drs Alicia Morgans and Evan Yu (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and Evan Yu, moderated by Dr Neil Love.

]]>Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and Evan Yu, moderated by Dr Neil Love.

]]>E1878516-FD7F-4BD3-A1F5-F7CFE5C73FEEWed, 16 Nov 2022 11:55:00 -040001:02:51falsefull224422Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in prostate and bladder cancers. Featuring perspectives from Drs Alicia Morgans and Evan Yu, moderated by Dr Neil Love.The Clinical Implications of Key Recent Data Sets in Renal Cell Carcinoma — With Prof Thomas Powles (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)The Clinical Implications of Key Recent Data Sets in Renal Cell Carcinoma — With Prof Thomas Powles (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in renal cell carcinoma. Featuring perspectives from Prof Thomas Powles, moderated by Dr Neil Love.

]]>Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in renal cell carcinoma. Featuring perspectives from Prof Thomas Powles, moderated by Dr Neil Love.

]]>63E002B7-3678-4422-BFEF-8279C1AD03C0Wed, 16 Nov 2022 11:55:00 -040021:21falsefull223322Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in renal cell carcinoma. Featuring perspectives from Prof Thomas Powles, moderated by Dr Neil Love.Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1 of a 2-Part SeriesMeet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1 of a 2-Part SeriesFeaturing a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Dr Matthew Smith, moderated by Dr Neil Love.

]]>Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Dr Matthew Smith, moderated by Dr Neil Love.

]]>15179630-54B1-4DED-8A7B-AA4FBE63850CWed, 09 Nov 2022 09:28:00 -040001:05:52falsefull222222Featuring a discussion on optimizing the use of hormonal therapy in the management of prostate cancer with Dr Matthew Smith, moderated by Dr Neil Love.Oncology Today with Dr Neil Love: Neuroendocrine TumorsOncology Today with Dr Neil Love: Neuroendocrine TumorsFeaturing a discussion on recent advances in understanding and treating neuroendocrine tumors with Dr Pamela Kunz, moderated by Dr Neil Love.

]]>Featuring a discussion on recent advances in understanding and treating neuroendocrine tumors with Dr Pamela Kunz, moderated by Dr Neil Love.

]]>5BCFB0DA-CBEE-4FE5-9D24-04F305435DB1Tue, 01 Nov 2022 11:05:00 -040038:22falsefull221122Featuring a discussion on recent advances in understanding and treating neuroendocrine tumors with Dr Pamela Kunz, moderated by Dr Neil Love.